Revision as of 11:15, 19 January 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report errors or [[user talk← Previous edit | Revision as of 11:06, 15 February 2011 edit undoLuckas-bot (talk | contribs)929,662 editsm r2.7.1) (robot Adding: es:NBQXNext edit → | ||
Line 58: | Line 58: | ||
{{biochem-stub}} | {{biochem-stub}} | ||
] | |||
] | ] |
Revision as of 11:06, 15 February 2011
File:NBQX.png | |
Names | |
---|---|
IUPAC name 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzoquinoxaline -7-sulfonamide | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.149.984 |
KEGG | |
PubChem CID | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C12H8N4O6S |
Molar mass | 336.281 |
Appearance | brown/red powder |
Solubility in water | Soluble to 100 mM in DMSO |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione) is an AMPA receptor antagonist.
NBQX blocks AMPA receptors in micromolar concentrations (~10–20 µmol) and also blocks kainate receptors. In experiments, it is used to counter glutamate excitotoxicity. NBQX was found to have anticonvulsant activity in rodent seizure models.
As the disodium salt, NBQX is soluble in water at high concentrations (<30 mmol).
References
- Pitt, D.; Werner, P.; Raine, C. S. (2000). "Glutamate excitotoxicity in a model of multiple sclerosis". Nat Med. 6 (1): 67–70.
- Yamaguchi, S.; Donevan, S.D.; Rogawski, M.A. (1993). Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res. 15:179–184.
This biochemistry article is a stub. You can help Misplaced Pages by expanding it. |